Get 20% lifetime commission for referring investors to digrin.com
here.
Immix Biopharma, Inc. ( IMMX) - Key Metrics
IMMX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.18 | -$0.18 | -$0.18 |
| 2026Q1 | $0 | -$0.18 | -$0.18 | -$0.18 |
| 2025Q4 | $0 | -$0.28 | -$0.29 | -$0.29 |
| 2025Q3 | $0 | -$0.24 | -$0.18 | -$0.20 |
| 2025Q2 | $0 | -$0.22 | -$0.18 | -$0.18 |
IMMX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -14.32 |
| 2026Q1 | 0% | -12.65 |
| 2025Q4 | 0% | -4.67 |
| 2025Q3 | 0% | -2.18 |
| 2025Q2 | 0% | -2.35 |
IMMX
Price: $11.34
52 week price:
Earnings Per Share: -0.88 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 12035
Market Capitalization: 781.0 million